Cardiorenal risk factors

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The chronic renocardiac syndrome, in which chronic kidney disease (CKD) contributes to impairment of cardiac function or structure, is associated with an increased risk of adverse cardiovascular events. The prevalence of CKD in the U.S. population is approximately 11% and has been increasing over time. Numerous studies have demonstrated an association of CKD, defined by the presence of reduced glomerular filtration rate and/or albuminuria with adverse cardiovascular and renal outcomes. These data suggest that both albuminuria and glomerular filtration rate, which can be performed with minimally increased costs, should be included in the assessment of risk stratification for individual patients, in addition to traditional cardiovascular risk factors.

Original languageEnglish (US)
Pages (from-to)25-29
Number of pages5
JournalAmerican Journal of the Medical Sciences
Volume340
Issue number1
DOIs
StatePublished - Jul 1 2010

Fingerprint

Chronic Renal Insufficiency
Albuminuria
Glomerular Filtration Rate
Cardio-Renal Syndrome
Kidney
Costs and Cost Analysis
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Cardiorenal risk factors. / Wall, Barry.

In: American Journal of the Medical Sciences, Vol. 340, No. 1, 01.07.2010, p. 25-29.

Research output: Contribution to journalArticle

@article{523fae6ba00746ab9f990a071ac49281,
title = "Cardiorenal risk factors",
abstract = "The chronic renocardiac syndrome, in which chronic kidney disease (CKD) contributes to impairment of cardiac function or structure, is associated with an increased risk of adverse cardiovascular events. The prevalence of CKD in the U.S. population is approximately 11{\%} and has been increasing over time. Numerous studies have demonstrated an association of CKD, defined by the presence of reduced glomerular filtration rate and/or albuminuria with adverse cardiovascular and renal outcomes. These data suggest that both albuminuria and glomerular filtration rate, which can be performed with minimally increased costs, should be included in the assessment of risk stratification for individual patients, in addition to traditional cardiovascular risk factors.",
author = "Barry Wall",
year = "2010",
month = "7",
day = "1",
doi = "10.1097/MAJ.0b013e3181e59078",
language = "English (US)",
volume = "340",
pages = "25--29",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cardiorenal risk factors

AU - Wall, Barry

PY - 2010/7/1

Y1 - 2010/7/1

N2 - The chronic renocardiac syndrome, in which chronic kidney disease (CKD) contributes to impairment of cardiac function or structure, is associated with an increased risk of adverse cardiovascular events. The prevalence of CKD in the U.S. population is approximately 11% and has been increasing over time. Numerous studies have demonstrated an association of CKD, defined by the presence of reduced glomerular filtration rate and/or albuminuria with adverse cardiovascular and renal outcomes. These data suggest that both albuminuria and glomerular filtration rate, which can be performed with minimally increased costs, should be included in the assessment of risk stratification for individual patients, in addition to traditional cardiovascular risk factors.

AB - The chronic renocardiac syndrome, in which chronic kidney disease (CKD) contributes to impairment of cardiac function or structure, is associated with an increased risk of adverse cardiovascular events. The prevalence of CKD in the U.S. population is approximately 11% and has been increasing over time. Numerous studies have demonstrated an association of CKD, defined by the presence of reduced glomerular filtration rate and/or albuminuria with adverse cardiovascular and renal outcomes. These data suggest that both albuminuria and glomerular filtration rate, which can be performed with minimally increased costs, should be included in the assessment of risk stratification for individual patients, in addition to traditional cardiovascular risk factors.

UR - http://www.scopus.com/inward/record.url?scp=77954640416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954640416&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0b013e3181e59078

DO - 10.1097/MAJ.0b013e3181e59078

M3 - Article

VL - 340

SP - 25

EP - 29

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 1

ER -